312 related articles for article (PubMed ID: 26391982)
1. HMGB1/RAGE induces IL-17 expression to exaggerate inflammation in peripheral blood cells of hepatitis B patients.
Jhun J; Lee S; Kim H; Her YM; Byun JK; Kim EK; Lee SK; Cho ML; Choi JY
J Transl Med; 2015 Sep; 13():310. PubMed ID: 26391982
[TBL] [Abstract][Full Text] [Related]
2. Involvement of HMGB1 and RAGE in IL-1β-induced gingival inflammation.
Ito Y; Bhawal UK; Sasahira T; Toyama T; Sato T; Matsuda D; Nishikiori H; Kobayashi M; Sugiyama M; Hamada N; Arakawa H; Kuniyasu H
Arch Oral Biol; 2012 Jan; 57(1):73-80. PubMed ID: 21861984
[TBL] [Abstract][Full Text] [Related]
3. [Effect of high mobility group box protein 1 on the Kupffer cells of rats with severe burn and the role of receptor for advanced glycation end products in the process].
Sun L; Chen XL; Guo F; Wang F; Liu S; Liang X; Wang RS; Wang YJ; Sun YX
Zhonghua Shao Shang Za Zhi; 2013 Apr; 29(2):158-61. PubMed ID: 23985205
[TBL] [Abstract][Full Text] [Related]
4. HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis.
Muth IE; Zschüntzsch J; Kleinschnitz K; Wrede A; Gerhardt E; Balcarek P; Schreiber-Katz O; Zierz S; Dalakas MC; Voll RE; Schmidt J
Exp Neurol; 2015 Sep; 271():189-97. PubMed ID: 26048613
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of post-hemorrhagic shock mesenteric lymph drainage on the HMGB1 and RAGE in mouse kidney.
Liu GQ; Zuo XH; Jiang LN; Zhang YP; Zhang LM; Zhao ZG; Niu CY
Ren Fail; 2016; 38(1):131-6. PubMed ID: 26513053
[TBL] [Abstract][Full Text] [Related]
6. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease.
Ferhani N; Letuve S; Kozhich A; Thibaudeau O; Grandsaigne M; Maret M; Dombret MC; Sims GP; Kolbeck R; Coyle AJ; Aubier M; Pretolani M
Am J Respir Crit Care Med; 2010 May; 181(9):917-27. PubMed ID: 20133931
[TBL] [Abstract][Full Text] [Related]
7. High-Mobility Group Box 1 Is Associated with the Inflammatory Pathogenesis of Graves' Orbitopathy.
Han SY; Choi SH; Shin JS; Lee EJ; Han SH; Yoon JS
Thyroid; 2019 Jun; 29(6):868-878. PubMed ID: 30973094
[No Abstract] [Full Text] [Related]
8. High-mobility group box 1 impairs airway epithelial barrier function through the activation of the RAGE/ERK pathway.
Huang W; Zhao H; Dong H; Wu Y; Yao L; Zou F; Cai S
Int J Mol Med; 2016 May; 37(5):1189-98. PubMed ID: 27035254
[TBL] [Abstract][Full Text] [Related]
9. Modulation of HMGB1 translocation and RAGE/NFκB cascade by quercetin treatment mitigates atopic dermatitis in NC/Nga transgenic mice.
Karuppagounder V; Arumugam S; Thandavarayan RA; Pitchaimani V; Sreedhar R; Afrin R; Harima M; Suzuki H; Nomoto M; Miyashita S; Suzuki K; Nakamura M; Watanabe K
Exp Dermatol; 2015 Jun; 24(6):418-23. PubMed ID: 25739980
[TBL] [Abstract][Full Text] [Related]
10. Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis.
Yu SL; Wong CK; Szeto CC; Li EK; Cai Z; Tam LS
Lupus; 2015 Jun; 24(7):675-86. PubMed ID: 25411258
[TBL] [Abstract][Full Text] [Related]
11. Uric Acid Induces Endothelial Dysfunction by Activating the HMGB1/RAGE Signaling Pathway.
Cai W; Duan XM; Liu Y; Yu J; Tang YL; Liu ZL; Jiang S; Zhang CP; Liu JY; Xu JX
Biomed Res Int; 2017; 2017():4391920. PubMed ID: 28116308
[TBL] [Abstract][Full Text] [Related]
12. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
[TBL] [Abstract][Full Text] [Related]
13. IL-1β enhances vascular smooth muscle cell proliferation and migration via P2Y2 receptor-mediated RAGE expression and HMGB1 release.
Eun SY; Ko YS; Park SW; Chang KC; Kim HJ
Vascul Pharmacol; 2015 Sep; 72():108-17. PubMed ID: 25956731
[TBL] [Abstract][Full Text] [Related]
14. High motility group box 1 (HMGB1) protein and its receptor for advanced glycation end products (RAGE) expression in chronic rhinosinusitis without nasal polyps.
Dzaman K; Zagor M; Molinska-Glura M; Krzeski A
Folia Histochem Cytobiol; 2015; 53(1):70-8. PubMed ID: 25772690
[TBL] [Abstract][Full Text] [Related]
15. HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi.
Ahrens I; Chen YC; Topcic D; Bode M; Haenel D; Hagemeyer CE; Seeba H; Duerschmied D; Bassler N; Jandeleit-Dahm KA; Sweet MJ; Agrotis A; Bobik A; Peter K
Thromb Haemost; 2015 Nov; 114(5):994-1003. PubMed ID: 26202300
[TBL] [Abstract][Full Text] [Related]
16. Decreased level of sRAGE in the cerebrospinal fluid of multiple sclerosis patients at clinical onset.
Glasnović A; Cvija H; Stojić M; Tudorić-Đeno I; Ivčević S; Romić D; Tičinović N; Vuletić V; Lazibat I; Grčević D
Neuroimmunomodulation; 2014; 21(5):226-33. PubMed ID: 24603633
[TBL] [Abstract][Full Text] [Related]
17. Expression and cell distribution of receptor for advanced glycation end-products in the rat cortex following experimental subarachnoid hemorrhage.
Li H; Wu W; Sun Q; Liu M; Li W; Zhang XS; Zhou ML; Hang CH
Brain Res; 2014 Jan; 1543():315-23. PubMed ID: 24291745
[TBL] [Abstract][Full Text] [Related]
18. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
Basta G; Del Turco S; Navarra T; Lee WM;
Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
[TBL] [Abstract][Full Text] [Related]
19. HMGB1 promotes the synthesis of pro-IL-1β and pro-IL-18 by activation of p38 MAPK and NF-κB through receptors for advanced glycation end-products in macrophages.
He Q; You H; Li XM; Liu TH; Wang P; Wang BE
Asian Pac J Cancer Prev; 2012; 13(4):1365-70. PubMed ID: 22799333
[TBL] [Abstract][Full Text] [Related]
20. Expression of the receptor for advanced glycation end products, a target for high mobility group box 1 protein, and its role in chronic recalcitrant rhinosinusitis with nasal polyps.
Dzaman K; Szczepanski MJ; Molinska-Glura M; Krzeski A; Zagor M
Arch Immunol Ther Exp (Warsz); 2015 Jun; 63(3):223-30. PubMed ID: 25503556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
